Latest Myostatin Stories

Lee Rannals for redOrbit.com – Your Universe Online A study may be paving the way for finding ways to prevent muscle loss, obesity and diabetes. Researchers from Nanyang Technological University (NTU) found that by inhibiting a particular molecule produced naturally in the body, muscle loss due to aging or illness can be prevented. By blocking this same molecule, it triggers the body to go into a "fat-burning mode" which will fight obesity, and also treat the most common form of...

CLEVELAND, Dec. 12, 2012 /PRNewswire/ -- Milo Biotechnology today announced its AAV1-FS344 has been granted Orphan Drug designation from the FDA's Office of Orphan Products Development for treatment of Becker and Duchenne muscular dystrophy. AAV1-FS344 is a gene therapy-delivered myostatin inhibitor that increases muscle strength. The program is currently in a Phase I/II trial at Nationwide Children's Hospital in adult patients with Becker muscular dystrophy and inclusion body...

Implications for treating muscular dystrophy and other muscle wasting diseases Working with mice, Johns Hopkins researchers have solved a key part of a muscle regeneration mystery plaguing scientists for years, adding strong support to the theory that muscle mass can be built without a complete, fully functional supply of muscle stem cells. "This is good news for those with muscular dystrophy and other muscle wasting disorders that involve diminished stem cell function," says Se-Jin...

The study of muscular system protein myostatin has been of great interest to researchers as a potential therapeutic target for people with muscular disorders. Although much is known about how myostatin affects muscle growth, there has been disagreement about what types of muscle cells it acts upon. New research from a team including Carnegie's Chen-Ming Fan and Christoph Lepper narrows down the field to one likely type of cell. Their work is published the week of August 6 by Proceedings of...

CLEVELAND, Feb. 14, 2012 /PRNewswire/ -- Milo Biotechnology will receive $250,000 from JumpStart Inc., a nonprofit investing intensive business assistance and some capital into early stage Northeast Ohio-based tech companies. A clinical stage startup developing a therapy to increase muscle strength and improve the quality of life of muscular dystrophy patients, Milo is the 61st company in JumpStart's portfolio. "There are limited treatment options for muscular dystrophy and...

(Ivanhoe Newswire) – Super strong mice and marathon mice and nematodes were created by reducing the function of a natural inhibitor, suggesting treatments for age-related or genetically caused muscle degeneration are within reach. It turns out that a tiny inhibitor may be responsible for how strong and powerful our muscles can be. This is the surprising conclusion reached by scientists in EPFL's Laboratory of Integrative Systems Physiology (LISP), in collaboration with a group in the...

Salk scientists and their collaborators find new avenue for treating muscle degeneration in people who can't exercise An international team of scientists has created super-strong, high-endurance mice and worms by suppressing a natural muscle-growth inhibitor, suggesting treatments for age-related or genetics-related muscle degeneration are within reach. The project was a collaboration between researchers at the Salk Institute for Biological Studies, and two Swiss institutions, Ecole...

A team of researchers at EPFL, the University of Lausanne and the Salk Institute created super strong, marathon mice and nematodes by reducing the function of a natural inhibitor, suggesting treatments for age-related or genetically caused muscle degeneration are within reach. It turns out that a tiny inhibitor may be responsible for how strong and powerful our muscles can be. This is the surprising conclusion reached by scientists in EPFL's Laboratory of Integrative Systems Physiology...

Atlas Therapeutics is pleased to announce that its revolutionary weight-training supplement, Myo-T12, is now available for purchase on RonnieColemanNutrition.com. Delray Beach, FL (PRWEB) August 08, 2011 Atlas Therapeutics is pleased to announce that its revolutionary weight-training supplement, Myo-T12, is now available for purchase on RonnieColemanNutrition.com. Myo-T12, which is the world's first clinically validated myostatin inhibitor, provides a better and healthier way for...

Atlas Therapeutics Corporation (OTCBB: ATTH), the manufacturer of the revolutionary myostatin inhibitor, MYO-T12®, has announced that hockey legend Wayne Gretzky is joining its primary national promotion and marketing team. Marina Del Rey, CA (PRWEB) July 01, 2011 Atlas Therapeutics Corporation (OTCBB: ATTH), the manufacturer of the revolutionary myostatin inhibitor, MYO-T12®, has announced that hockey legend Wayne Gretzky is joining its primary national promotion and marketing...